Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Lu Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5216-3843; OpenAlex author ID A5100776416. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2017: 3 papers · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 5

  1. Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer. Co-author DOI 10.1038/s41467-024-47242-3↗
  2. The overexpression of long intergenic ncRNA00162 induced by RelA/p65 promotes growth of pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/cpr.12805↗
  3. NEMO peptide inhibits the growth of pancreatic ductal adenocarcinoma by blocking NF-κB activation. Co-author DOI 10.1016/j.canlet.2017.09.018↗
  4. Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/ncomms14437↗
  5. Inhibition of Pancreatic Cancer by RhIL1RA-Response. Co-author DOI 10.1158/1078-0432.ccr-17-0083↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianhua Ling · 5 shared papers, 2017–2024 · strength 0.47
  2. Paul J. Chiao · 5 shared papers, 2017–2024 · strength 0.47
  3. Jie Fu · 4 shared papers, 2017–2024 · strength 0.38
  4. Kenei Furukawa · 2 shared papers, 2020–2024 · strength 0.26
  5. Huamin Wang · 2 shared papers, 2017–2024 · strength 0.20
  6. Jun Yao · 2 shared papers, 2017–2024 · strength 0.20
  7. Mien‐Chie Hung · 2 shared papers, 2017–2024 · strength 0.20
  8. Peng Huang · 2 shared papers, 2017–2024 · strength 0.20
  9. Ping Chen · 1 shared paper, 2024 · strength 0.14
  10. Ching-Fei Li · 1 shared paper, 2024 · strength 0.14
  11. Ya’an Kang · 1 shared paper, 2024 · strength 0.14
  12. Qian Huang · 1 shared paper, 2024 · strength 0.14
  13. Jun Zhao · 1 shared paper, 2024 · strength 0.14
  14. Wenjuan Yin · 1 shared paper, 2024 · strength 0.14
  15. Jason B. Fleming · 1 shared paper, 2024 · strength 0.14
  16. Anirban Maitra · 1 shared paper, 2024 · strength 0.14
  17. Xue Ying Qin · 1 shared paper, 2020 · strength 0.12
  18. Zhuonan Zhuang · 2 shared papers, 2017 · strength 0.11
  19. Huai‐Qiang Ju · 2 shared papers, 2017 · strength 0.11
  20. Yi-Chen Sun · 1 shared paper, 2017 · strength 0.09
  21. Jie Fu · 1 shared paper, 2017 · strength 0.09
  22. Lifeng Yang · 1 shared paper, 2017 · strength 0.05
  23. Haoqiang Ying · 1 shared paper, 2017 · strength 0.05
  24. Ronald Anthony Depinho · 1 shared paper, 2017 · strength 0.05
  25. Rui‐Hua Xu · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.